Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | NMT1 |
| Gene Name: | NMT1 |
| Protein Full Name: | Glycylpeptide N-tetradecanoyltransferase 1 |
| Alias: | Alternative, short form NMT-S; Long form, NMT-L; Myristoyl-CoA:protein N-myristoyltransferase; Myristoyl-CoA:protein N-myristoyltransferase 1; NMT; N-myristoyltransferase 1; Peptide N- myristoyltransferase 1; Peptide N-myristoyltransferase 1; Type I N-myristoyltransferase |
| Mass (Da): | 56806 |
| Number AA: | 496 |
| UniProt ID: | P30419 |
| Locus ID: | 4836 |
| COSMIC ID: | NMT1 |
| Gene location on chromosome: | 17q21.31 |
| Cancer protein type: | OP |
| Effect of cancer mutation on protein: | GAIN |
| Effect of active protein on cancer: | PROMOTES |
| Number of cancer specimens: | 19625 |
| Percent of cancer specimens with mutations: | 0.29 |
| Normal role description: | NMT1 is a myristoyltransferase enzyme that attaches myrsitate fatty acids from CoA to various proteins. Upregulation of this gene has been found in breast, colon, and lung tumors. |